CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q1 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $34,764,000 | -31.7% | 310,392 | -52.0% | 4.40% | -26.9% |
Q3 2020 | $50,915,000 | +9.3% | 647,195 | 0.0% | 6.02% | +17.4% |
Q2 2020 | $46,592,000 | -25.1% | 647,195 | -33.2% | 5.13% | +142.8% |
Q4 2018 | $62,220,000 | -34.8% | 969,160 | -19.6% | 2.11% | +14.9% |
Q3 2018 | $95,448,000 | -24.4% | 1,204,851 | -30.1% | 1.84% | -16.7% |
Q2 2018 | $126,200,000 | -8.3% | 1,724,045 | -20.7% | 2.20% | -20.0% |
Q1 2018 | $137,682,000 | -2.6% | 2,174,045 | -21.6% | 2.76% | +8.6% |
Q4 2017 | $141,393,000 | -2.9% | 2,774,045 | 0.0% | 2.54% | +10.2% |
Q3 2017 | $145,554,000 | +3.0% | 2,774,045 | 0.0% | 2.30% | -21.1% |
Q2 2017 | $141,310,000 | +14.7% | 2,774,045 | 0.0% | 2.92% | +28.1% |
Q1 2017 | $123,195,000 | +0.5% | 2,774,045 | 0.0% | 2.28% | -2.0% |
Q4 2016 | $122,530,000 | +10.3% | 2,774,045 | 0.0% | 2.32% | +18.4% |
Q3 2016 | $111,128,000 | -16.1% | 2,774,045 | 0.0% | 1.96% | -28.3% |
Q2 2016 | $132,405,000 | +32.6% | 2,774,045 | +16.5% | 2.73% | +46.9% |
Q1 2016 | $99,828,000 | – | 2,380,264 | – | 1.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |